Concentrix Posts Mixed Q3 Results, Joins Cal-Maine Foods And Other Big Stocks Moving Lower In Wednesday’s Pre-Market Session
Concentrix plunged 10.6% premarket after weak guidance, despite an earnings beat; several other stocks also traded lower.
Stocks · News reference
Chimera Investment shares are trading lower after the company reported worse-than-expected Q2 financial results.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Keefe, Bruyette & Woods Maintains Market Perform on Chimera Investment, Lowers Price Target to $14
Keefe, Bruyette & Woods analyst Bose George maintains Chimera Investment (NYSE:CIM) with a Market Perform and lowers the price target from $15 to $14.
CORRECTION: Chimera Investment Q2 Adj. EPS $0.46 Misses $0.54 Estimate, Sales $70.509M Miss $95.423M Estimate
Chimera Investment (NYSE:CIM) reported quarterly earnings of $0.46 per share which missed the analyst consensus estimate of $0.54 by 14.81 percent. This is a 17.95 percent increase over earnings of $0.39 per share from